A first-in-human study in healthy subjects of the safety and pharmacokinetics of CNM-Au8, a suspension of catalytically active gold nanocrystals with remyelinating and neuroprotective properties

KMS Kanhai, RGJA Zuiker, W Houghton, WG Kramer, K McBride, M Moerland, Adam Dorfman, Misty McGlothlin, M Hotchkin, M Mortenson, R Etherington, GJ Groeneveld
doi: https://doi.org/10.1101/2023.05.11.23289871

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted May 16, 2023.
Download PDF
Data/Code
Email
A first-in-human study in healthy subjects of the safety and pharmacokinetics of CNM-Au8, a suspension of catalytically active gold nanocrystals with remyelinating and neuroprotective properties
KMS Kanhai, RGJA Zuiker, W Houghton, WG Kramer, K McBride, M Moerland, Adam Dorfman, Misty McGlothlin, M Hotchkin, M Mortenson, R Etherington, GJ Groeneveld
medRxiv 2023.05.11.23289871; doi: https://doi.org/10.1101/2023.05.11.23289871
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area